incubations c2c12 mouse skeletal muscle cells (ATCC)
Structured Review

Incubations C2c12 Mouse Skeletal Muscle Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8618 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/incubations+c2c12+mouse+skeletal+muscle+cells/C2C12/pmc03939833-61-3-13
Average 99 stars, based on 8618 article reviews
Images
1) Product Images from "Apoptosis in differentiating C2C12 muscle cells selectively targets Bcl-2-deficient myotubes"
Article Title: Apoptosis in differentiating C2C12 muscle cells selectively targets Bcl-2-deficient myotubes
Journal: Apoptosis : an international journal on programmed cell death
doi: 10.1007/s10495-013-0922-7
Figure Legend Snippet: (a) – Phase contrast light microscopy of proliferating myoblasts and myotubes formed on day 6 of differentiation. (b) - WB analysis of specific protein marker expression during C2C12 cell differentiation assessed with antibodies against myogenin, SERCA1, Cav3, and Cav1. Actin expression levels are shown as controls for protein load. (c) – Myotubes and reserve cells were separated at days 4 (4d) and 6 (6d) of differentiation, as shown in the schematic representation and described under “Experimental Procedures”, and analyzed by WB with antibodies specific for myogenin, SERCA1, Cav3, and Cav1. The abbreviations used for the cell types are M - proliferating myoblasts; T – myotubes; R - reserve cells.
Techniques Used: Light Microscopy, Marker, Expressing, Cell Differentiation
Figure Legend Snippet: (a) - Proliferating myoblasts (day 0) and differentiating C2C12 cells were harvested on days 2 - 6 after the onset of differentiation and analyzed by SDS-PAGE and WB analysis with antibodies against Hsp70, Bcl-2, Bax, Bak, and Bad. (b) – Analysis of these proteins separately in myoblasts (M), myotubes (T) and reserve cells (R) along with cell type-specific protein markers Pax7 and MyoD at days 4 (4d) and day 6 (6d) of differentiation. (c) Densitometry analysis of data from (b).
Techniques Used: SDS Page
Figure Legend Snippet: (a) – Sequence specificity of SERCA2A and SERCA2B in the C-terminal part. (b) – WB analysis of protein expression during C2C12 cell differentiation assessed with antibodies against SERCA2. (c) - Densitometry analysis of WB data of SERCA2 level in GM and in DM after 6 days of differentiation from three independent experiments.(d) – Analysis of SERCA2 isoforms separately in myoblasts (M), myotubes (T) and reserve cells (R): myotubes and reserve cells were separated as described under “Experimental Procedures” at day 6 of differentiation and analyzed by WB with antibodies specific for SERCA2 and SERCA2B (polyclonal custom antibody raised against the C-terminal peptide underlined in panel A). (e) - Capillary LC-LTQ-FT-MS/MS spectrum of the C-terminal tryptic peptide of SERCA2A, identified in the tryptic digests of C2C12 cell lysates.
Techniques Used: Sequencing, Expressing, Cell Differentiation, Tandem Mass Spectroscopy
Figure Legend Snippet: Phase contrast light microscopy of differentiated C2C12 cells prior to (a) and after exposure to 0.5 (b), 1 (c), 2 (d), and 4 mM H2O2 (e) for 4 h or 2 h (f) as described under “Experimental Procedures”.
Techniques Used: Light Microscopy
Figure Legend Snippet: Differentiated C2C12 cells were incubated without (control) or with 4 mM H2O2 for different times as indicated (a) or incubated overnight with smaller concentrations of H2O2 (b), and adherent cells were analyzed by WB with anti-SERCA1, anti-Cav3 and anti-Bcl-2 antibodies. Actin expression levels are presented for control of protein load. (c) Differentiated C2C12 cells were incubated in the absence or in the presence of 4 mM H2O2 for 4 h, and expression levels of SERCA1 and Bcl-2 were analyzed by WB separately for adherent and detached cells.
Techniques Used: Incubation, Control, Expressing
Figure Legend Snippet: (a) – Detached cells obtained after different treatment were harvested as depicted in the inserted scheme and analyzed by WB for Cav3, Bcl-2, and actin. (b) – Differentiated C2C12 cells treated as above were lysed, digested with trypsin, and submitted to a “shotgun” capLC-LTQ-FT-MS/MS analysis coupled to a protein database search, followed by a quantification of peptide TIC values for selected proteins as described under “Experimental Procedures”. Protein IDs in the IPI (mouse) database: SERCA1, 00311654; SERCA2, 00468900; Myosin light chain, skeletal muscle, 00224549; Myosin 3, 00380895; Myosin 9, 00123181; Troponin c, slow-twitch skeletal muscle, 00113712; Tubulin beta, 00117352. (Note: error bars on logarithmic scale).
Techniques Used: Tandem Mass Spectroscopy
Figure Legend Snippet: Differentiated C2C12 cells were incubated without (control) or in the presence of 4 mM of H2O2 for 2 h as shown in the schematic representation, and myotubes and reserve cells were separated by mild trypsinization as described under “Experimental Procedure”. (a) – Scheme of experiment. (b) – Expression profiles of Bcl-2, SERCA1, Cav3, and Pax7 in myotubes and reserve cells analyzed by WB after incubation without (control) or with 4 mM H2O2 for 2 h. (c) - Bcl-2 levels in non-treated myotubes (control) and myotubes remaining attached to the dish after incubation with 4 mM H2O2 for 2 h, collected by mild trypsinization, and analyzed by a densitometry analysis of the respective blots presented in panel B.
Techniques Used: Incubation, Control, Expressing
Figure Legend Snippet: Proliferating C2C12 myoblasts were transfected with either empty vector or Bcl-2 expression vector for 24 h before the onset of differentiation. (a) - Cells detached from the dishes at days 2, 4, and 6 after the initiation of differentiation were harvested and analyzed by WB for Bcl-2, SERCA1, Cav3 and caspase 9. (b) - Myotubes and reserve cells remaining attached to the dishes at day 6 after initiation of differentiation were separated via differential trypsinization as described under “Experimental Procedures”, and analyzed by WB with anti-Bcl-2 and anti-Bax antibodies. (c) – Control and Bcl-2 transfected C2C12 cells at day 6 after initiation of differentiation were incubated without or with 4 mM H2O2 for 2 hours, followed by WB analysis for Cav3, Bcl-2, and caspase 9 of both adherent and detached cells. (d) - Densitometry quantification of Cav-3 on the blots (marker of myotubes) shown in panel C, normalized to the level of Cav-3 in Bcl-2 transfected cells, remaining adherent to the dish after exposure to 4 mM H2O2 for 2 hours.
Techniques Used: Transfection, Plasmid Preparation, Expressing, Control, Incubation, Marker
Related Articles
Cell Culture:Article Title: Apoptosis in differentiating C2C12 muscle cells selectively targets Bcl-2-deficient myotubes Article Snippet: .. Cell Culture and |